GTC Biotherapeutics (fka GTCB)

[wjlknew]

>The author of that piece is deeply confused<

Dew,

It sounds like you are saying that anyone with an opinion which differs from yours is "deeply confused". At this point is not the definition of "FOB" effectively "after the patent expires"? The requirements for FOB approval are yet to be determined. She has her opinion of what those requirements should be, and you have yours. She may very well have a bias, but so do you.

It all boils down to whose ox is being gored. Let's hope Congress and the FDA will not let it be the patient's ox. (I say "hope" because "trust" is a little strong for either Congress or the FDA.) It will probably boil down to which side has the most effective lobby. Would you agree?